Research Progress of LINE-1 in the Diagnosis, Prognosis, and Treatment of Gynecologic Tumors

Overview

Journal Front Oncol

Specialty Oncology

Date 2023 Aug 7

PMID 37546391

Authors

Jiaojiao Fu

Tiansheng Qin

Chaoming Li

Jiaojiao Zhu

Yaoyao Ding

Meiying Zhou

Qing Yang

Xiaofeng Liu

Juanhong Zhou

Fan Chen

Affiliations

Soon will be listed here.

Abstract

The retrotransposon known as long interspersed nuclear element-1 (LINE-1), which is currently the sole autonomously mobile transposon in the human genome, can result in insertional mutations, chromosomal rearrangements, and genomic instability. In recent years, numerous studies have shown that LINE-1 is involved in the development of various diseases and also plays an important role in the immune regulation of the organism. The expression of LINE-1 in gynecologic tumors suggests that it is expected to be an independent indicator for early diagnosis and prognosis, and also, as a therapeutic target, LINE-1 is closely associated with gynecologic tumor prognosis. This article discusses the function of LINE-1 in the diagnosis, treatment, and prognosis of ovarian, cervical, and endometrial malignancies, as well as other gynecologic malignancies. It offers fresh perspectives on the early detection of tumors and the creation of novel anti-tumor medications.

References

Harris C, Normart R, Yang Q, Stevenson E, Haffty B, Ganesan S . Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomes. Genes Cancer. 2010; 1(2):115-24. PMC: 2952938. DOI: 10.1177/1947601909360812. View

Ardeljan D, Steranka J, Liu C, Li Z, Taylor M, Payer L . Cell fitness screens reveal a conflict between LINE-1 retrotransposition and DNA replication. Nat Struct Mol Biol. 2020; 27(2):168-178. PMC: 7080318. DOI: 10.1038/s41594-020-0372-1. View

Liang W, Xu J, Yuan W, Song X, Zhang J, Wei W . APOBEC3DE Inhibits LINE-1 Retrotransposition by Interacting with ORF1p and Influencing LINE Reverse Transcriptase Activity. PLoS One. 2016; 11(7):e0157220. PMC: 4948907. DOI: 10.1371/journal.pone.0157220. View

Jang H, Shah N, Du A, Dailey Z, Pehrsson E, Godoy P . Transposable elements drive widespread expression of oncogenes in human cancers. Nat Genet. 2019; 51(4):611-617. PMC: 6443099. DOI: 10.1038/s41588-019-0373-3. View

Kim Y, Rhee Y, Wen X, Cho N, Bae J, Kim W . Combination of L1 methylation and tumor-infiltrating lymphocytes as prognostic marker in advanced gastric cancer. Gastric Cancer. 2019; 23(3):464-472. DOI: 10.1007/s10120-019-01025-8. View

Wang X, Zhang Y, Yang N, Cheng H, Sun Y . DNMT3a mediates paclitaxel-induced abnormal expression of LINE-1 by increasing the intragenic methylation. Yi Chuan. 2020; 42(1):100-111. DOI: 10.16288/j.yczz.19-258. View

Doucet-OHare T, Sharma R, Rodic N, Anders R, Burns K, Kazazian Jr H . Somatically Acquired LINE-1 Insertions in Normal Esophagus Undergo Clonal Expansion in Esophageal Squamous Cell Carcinoma. Hum Mutat. 2016; 37(9):942-54. PMC: 5548391. DOI: 10.1002/humu.23027. View

Kerachian M, Kerachian M . Long interspersed nucleotide element-1 (LINE-1) methylation in colorectal cancer. Clin Chim Acta. 2018; 488:209-214. DOI: 10.1016/j.cca.2018.11.018. View

Kou Y, Wang S, Ma Y, Zhang N, Zhang Z, Liu Q . A High Throughput Cell-Based Screen Assay for LINE-1 ORF1p Expression Inhibitors Using the In-Cell Western Technique. Front Pharmacol. 2022; 13:881938. PMC: 9171067. DOI: 10.3389/fphar.2022.881938. View

10.

Liu N, Lee C, Swigut T, Grow E, Gu B, Bassik M . Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators. Nature. 2017; 553(7687):228-232. PMC: 5774979. DOI: 10.1038/nature25179. View

11.

Hancks D, Kazazian Jr H . Roles for retrotransposon insertions in human disease. Mob DNA. 2016; 7:9. PMC: 4859970. DOI: 10.1186/s13100-016-0065-9. View

12.

Shademan M, Zare K, Zahedi M, Mozaffari H, Bagheri Hosseini H, Ghaffarzadegan K . Promoter methylation, transcription, and retrotransposition of LINE-1 in colorectal adenomas and adenocarcinomas. Cancer Cell Int. 2020; 20:426. PMC: 7466817. DOI: 10.1186/s12935-020-01511-5. View

13.

Morse B, Rotherg P, South V, Spandorfer J, Astrin S . Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature. 1988; 333(6168):87-90. DOI: 10.1038/333087a0. View

14.

Robbez-Masson L, Tie C, Conde L, Tunbak H, Husovsky C, Tchasovnikarova I . The HUSH complex cooperates with TRIM28 to repress young retrotransposons and new genes. Genome Res. 2018; 28(6):836-845. PMC: 5991525. DOI: 10.1101/gr.228171.117. View

15.

Sanchez-Luque F, Kempen M, Gerdes P, Vargas-Landin D, Richardson S, Troskie R . LINE-1 Evasion of Epigenetic Repression in Humans. Mol Cell. 2019; 75(3):590-604.e12. DOI: 10.1016/j.molcel.2019.05.024. View

16.

Zoch A, Auchynnikava T, Berrens R, Kabayama Y, Schopp T, Heep M . SPOCD1 is an essential executor of piRNA-directed de novo DNA methylation. Nature. 2020; 584(7822):635-639. PMC: 7612247. DOI: 10.1038/s41586-020-2557-5. View

17.

Tang Z, Steranka J, Ma S, Grivainis M, Rodic N, Huang C . Human transposon insertion profiling: Analysis, visualization and identification of somatic LINE-1 insertions in ovarian cancer. Proc Natl Acad Sci U S A. 2017; 114(5):E733-E740. PMC: 5293032. DOI: 10.1073/pnas.1619797114. View

18.

Ko E, Oh Y, Kim H, Eo W, Kim H, Ock M . Correlation of long interspersed element-1 open reading frame 1 and c-Met proto-oncogene protein expression in ovarian cancer. Genes Genomics. 2019; 41(11):1293-1299. DOI: 10.1007/s13258-019-00858-y. View

19.

Pattamadilok J, Huapai N, Rattanatanyong P, Vasurattana A, Triratanachat S, Tresukosol D . LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer. Int J Gynecol Cancer. 2007; 18(4):711-7. DOI: 10.1111/j.1525-1438.2007.01117.x. View

20.

Goodier J, Kazazian Jr H . Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell. 2008; 135(1):23-35. DOI: 10.1016/j.cell.2008.09.022. View